含F(xiàn)-框WD重復(fù)域蛋白7(FBXW7)活性蛋白
Active F-Box And WD Repeat Domain Containing Protein 7 (FBXW7)
AGO; CDC4; FBW7; FBX30; FBXW6; SEL-10; SEL10; Archipelago Homolog; F-box and WD-40 domain-containing protein 7
- 編號(hào)APJ890Mu01
- 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點(diǎn)7.3
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格10μg50μg200μg1mg5mg
- 價(jià)格¥ 1632¥ 4080¥ 8160¥ 24480¥ 61200
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實(shí)驗(yàn)
F-Box And WD Repeat Domain Containing Protein 7 (FBXW7), also known as FBW7 or CDC4, serves as a crucial component of the SCF E3 ubiquitin ligase complex. This tumor suppressor protein plays a pivotal role in maintaining cellular homeostasis by targeting several key oncoproteins for degradation. Through its ubiquitin ligase activity, FBXW7 regulates the stability of critical cell cycle regulators and signaling molecules including c-Myc, Cyclin E, Notch, and mTOR. The protein exists in three distinct isoforms that differ in their subcellular distribution and functional specialization. In human cancers, FBXW7 ranks among the most frequently mutated genes, with its inactivation observed across diverse malignancies such as colorectal carcinoma, T-cell acute lymphoblastic leukemia, and breast cancer.?Besides,Ring?Box?Protein?1?(RBX1) has been identified as an interactor of FBXW7, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant mouse FBXW7 and recombinant human RBX1 . Briefly, biotin-linked FBXW7 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μl were then transferred to RBX1-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μl stop solution to the wells and read at 450nm immediately. The binding activity of recombinant mouse FBXW7 and recombinant human RBX1 was shown in Figure 1, the EC50?for this effect is 2.20 μg/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
| APJ890Mu01 | 含F(xiàn)-框WD重復(fù)域蛋白7(FBXW7)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPJ890Mu01 | 含F(xiàn)-框WD重復(fù)域蛋白7(FBXW7)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ890Mu01 | 含F(xiàn)-框WD重復(fù)域蛋白7(FBXW7)多克隆抗體 | Testing in progress. |



